Name: Latest research reports of Concord Biotech Ltd. authored by SBI Securities and published by - Trendlyne research reports.
Item: Concord Biotech Ltd.
Rating: 3
Author: SBI Securities

Concord Biotech Ltd.

NSE: CONCORDBIO | BSE: 543960 | ISIN: INE338H01029 | Industry: Biotechnology
| Expensive Performer

1308.4000 -42.60 (-3.15%)

NSE Jan 19, 2026 13:09 PM

New 52W Low in past week

Volume: 24,418

Concord Biotech Ltd.

04 Aug 2023

1308.40

-3.15%

Concord Biotech limited IPO Note

IPO Note: Concord Biotech Ltd.

SBI Securities

Concord Biotech has lost -30.92% in the last 6 Months